Lisby Steen - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 18, 2024, Lisby Steen's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (SVP & CHIEF SCIENTIFIC OFFICER), and currently has 35,600 shares of Common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
Lisby Steen - Insider Non-Derivative Transactions of YMAB Common stock
Lisby Steen - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 19, 2024 | Acquisition -- (Common Stock) | 17800 | 0 | 35600 |
| Jan 18, 2023 | Acquisition -- (Common stock) | 17800 | 0 | 17800 |